Search results
Added:
1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Dr Paul Stevens discusses 2024 KDIGO guideline updates.
View more
Added:
6 months ago
HFSA 25 - Aficamten improves excercise capacity compared to metoprolol in patients with obstructive hypertrophic cardiomyopathy in a prespecified analysis of the MAPLE-HCM study.Dr Gregory Lewis joins us to discuss findings from a prespecified cardiopulmonary exercise testing analysis of the MAPLE-HCM trial, which reveals divergent effects between aficamten and metoprolol on exercise performance…
View more
Added:
6 months ago
Learn about revascularisation strategies in cardiogenic shock after acute MI, including culprit-only vs multivessel PCI, from Dr Tara Jones (University of Utah, US).This three-part video lecture series, part of Women As One’s CLIMB® 2025 Skills Training Programme, offers case-based insights into Coronary and Mechanical Support for Cardiogenic Shock, curated by Dr Alison Duncan and Dr Frederick…
View more
Added:
1 year ago
Intra-operative 4-chamber transesophageal echo (TEE) view: Intraoperative TEE in 4-chamber view showing a highly mobile mass with near cavity obliteration of the LA.
View more
Added:
6 months ago
Learn about the definition and implications of a shock diagnosis and systems of care and the role of the shock team from Dr Frederick Welt (University of Utah, US).This three-part video lecture series, part of Women As One’s CLIMB® 2025 Skills Training Programme, offers case-based insights into Coronary and Mechanical Support for Cardiogenic Shock, curated by Dr Alison Duncan and Dr Frederick…
View more
Added:
5 months ago
AHA Scientific Sessions 2025 - Dr Nils Krüger (Brigham and Women's Hospital, US) joins us to discuss findings from the TIRZSEMA-CVOT (NCT07096063) study, examining real-world cardiovascular outcomes with tirzepatide and semaglutide in patients with type 2 diabetes at cardiovascular risk.This retrospective cohort study utilized three national US claims databases to evaluate over 887,000 patients…
View more
Added:
1 year ago
AHA Conference 2024 - 128-week results of VALOR-HCM investigating mavacamten treatment for patients with hypertrophic cardiomyopathy (HCM) referred for septal reduction therapy (SRT) procedures.Dr Milind Desai (Cleveland Clinic, Ohio, US) joins us onsite at AHA Conference to discuss the findings from VALOR-HCM (NCT04349072).VALOR-HCM is a randomized, double-blind, placebo-controlled, phase 3…
View more
Added:
1 year ago
Parasternal long axis (PLAX) transthoracic echo view: PLAX view showing the mobile mass protruding through the mitral valve with near complete left atrial cavity obliteration.
View more
Added:
1 year ago
Cardiac MRI (cMRI) 4-chamber cine view: Cardiac MRI cine sequence showing a mobile, markedly T2 hyperintense mass, attached to the mid interatrial septum, extending through the mitral valve.
View more
Added:
1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Dr Muthiah Vaduganathan and Dr David Charytan discuss the practical implementation of non-steroidal mineralocorticoid receptor antagonists to reduce cardiorenal risk.
View more